These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 24053183)

  • 21. The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction.
    Altıntaş B; Altındağ R; Bilge Ö; Baysal E; Öztürk Ö; Yaylak B; Ede H; Karahan MZ; Burak C; Tanboğa İH
    Int J Cardiol; 2019 Jul; 287():19-26. PubMed ID: 30979602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
    JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids.
    Ilhan E; Demirci D; Güvenç TS; Calık AN
    Turk Kardiyol Dern Ars; 2010 Jun; 38(4):275-8. PubMed ID: 20935436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dabigatran Added to Dual Antiplatelet Therapy to Treat a Left Ventricular Thrombus in an 87 Year Old Patient With Myocardial Infarction and Very High Bleeding Risk.
    Noflatscher M; Moes N; Gassner EM; Marschang P
    Front Pharmacol; 2018; 9():217. PubMed ID: 29670522
    [No Abstract]   [Full Text] [Related]  

  • 26. Clopidogrel resistance in diabetic patient with acute myocardial infarction due to stent thrombosis.
    Samoš M; Šimonová R; Kovář F; Duraj L; Fedorová J; Galajda P; Staško J; Fedor M; Kubisz P; Mokáň M
    Am J Emerg Med; 2014 May; 32(5):461-5. PubMed ID: 24560391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of simultaneous anterior, inferior, and right ventricular ST-segment elevation myocardial infarction due to occlusion of the wrapped left anterior descending coronary artery.
    Akpinar I; Arat N; Ozbülbül NI
    Turk Kardiyol Dern Ars; 2008 Jul; 36(5):335-7. PubMed ID: 18984987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two Strikes: A Case Study of Consecutive St-Elevation Myocardial Infarctions (Stemi) in two Different Coronary Arteries.
    Chirumamilla Y; Chinnappan J; Alkotob ML
    Eur J Case Rep Intern Med; 2024; 11(5):004495. PubMed ID: 38715872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolution of left ventricular postinfarction thrombi in patients undergoing percutaneous coronary intervention using rivaroxaban in addition to dual antiplatelet therapy.
    Makrides CA
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27797850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
    Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Severe myocardial infarction due to late and very late stent thrombosis after coronary artery stenting with drug-eluting stents].
    Krausgrill B; Erdmann E; Flesch M
    Dtsch Med Wochenschr; 2008 Oct; 133(40):2014-7. PubMed ID: 18819044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraprocedural thrombus formation in the left main tract during primary percutaneous coronary intervention.
    Oh JH; Lee HC; Cha KS
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S163-5. PubMed ID: 25518758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute promyelocytic leukemia as a cause of intracoronary drug-eluting-stent thrombosis.
    Sargsyan Z; Higgins C; Alexandrescu S; Ott DA; Jain SK
    Tex Heart Inst J; 2012; 39(3):416-9. PubMed ID: 22719158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperdominant left anterior descending artery presenting as anterior wall ST segment elevation myocardial infarction: A rare coronary anomaly.
    Hashmani S; Laghari AH
    J Pak Med Assoc; 2019 May; 69(5):728-730. PubMed ID: 31105298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry.
    Nakamura M; Yamagishi M; Ueno T; Hara K; Ishiwata S; Itoh T; Hamanaka I; Wakatsuki T; Sugano T; Kawai K; Kimura T
    Cardiovasc Interv Ther; 2013 Apr; 28(2):162-9. PubMed ID: 23233418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction.
    Di Vito L; Versaci F; Limbruno U; Pawlowski T; Gatto L; Romagnoli E; Cattabiani MA; Micari A; Trivisonno A; Marco V; Prati F
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):701-6. PubMed ID: 27467458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.